0001192482-20-000029.txt : 20200106 0001192482-20-000029.hdr.sgml : 20200106 20200106083844 ACCESSION NUMBER: 0001192482-20-000029 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 EFFECTIVENESS DATE: 20200106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aro Biotherapeutics Co CENTRAL INDEX KEY: 0001773305 IRS NUMBER: 823212502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-357202 FILM NUMBER: 20508135 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET, SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-544-1175 MAIL ADDRESS: STREET 1: 3675 MARKET STREET, SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001773305 Aro Biotherapeutics Co 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA PENNSYLVANIA 19104 215-544-1175 DELAWARE None None Corporation true 2017 Susan B Dillon 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Karyn O'Neil 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Mark Laurenzi 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Elizabeth Anderson 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Bruce Peacock 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b false 2019-12-20 false true true false 0 5000000 5000000 0 false 1 0 0 0 false Aro Biotherapeutics Co /s/ Mark Laurenzi Mark Laurenzi Chief Administrative Officer 2019-12-27